Zeuzem S - Search Results

1

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.

Zeuzem S, Yoshida EM, Benhamou Y, Pianko S, Bain VG, Shouval D, Flisiak R, Rehak V, Grigorescu M, Kaita K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG. Zeuzem S, et al. Hepatology. 2008 Aug;48(2):407-17. doi: 10.1002/hep.22403. Hepatology. 2008. PMID: 18666223 Clinical Trial.

2

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

Lee SS, Heathcote EJ, Reddy KR, Zeuzem S, Fried MW, Wright TL, Pockros PJ, Häussinger D, Smith CI, Lin A, Pappas SC. Lee SS, et al. Among authors: zeuzem s. J Hepatol. 2002 Oct;37(4):500-6. doi: 10.1016/s0168-8278(02)00211-8. J Hepatol. 2002. PMID: 12217604 Clinical Trial.

3

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

Cornberg M, Hinrichsen H, Teuber G, Berg T, Naumann U, Falkenberg C, Zeuzem S, Manns MP. Cornberg M, et al. Among authors: zeuzem s. J Hepatol. 2002 Dec;37(6):843-7. doi: 10.1016/s0168-8278(02)00300-8. J Hepatol. 2002. PMID: 12445427

4

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.

Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Berg T, et al. Among authors: zeuzem s. Hepatology. 2003 Mar;37(3):600-9. doi: 10.1053/jhep.2003.50106. Hepatology. 2003. PMID: 12601358

5

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.

Rasenack J, Zeuzem S, Feinman SV, Heathcote EJ, Manns M, Yoshida EM, Swain MG, Gane E, Diago M, Revicki DA, Lin A, Wintfeld N, Green J. Rasenack J, et al. Among authors: zeuzem s. Pharmacoeconomics. 2003;21(5):341-9. doi: 10.2165/00019053-200321050-00005. Pharmacoeconomics. 2003. PMID: 12627987 Clinical Trial.

6

Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome.

Strnad-Trojan N, Linde R, Reichenbach J, Trojan J, Zeuzem S, Zielen S. Strnad-Trojan N, et al. Among authors: zeuzem s. Eur J Pediatr. 2006 May;165(5):348-50. doi: 10.1007/s00431-005-0062-3. Epub 2006 Feb 4. Eur J Pediatr. 2006. PMID: 16463052

7

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

Kronenberger B, Berg T, Herrmann E, Hinrichsen H, Gerlach T, Buggisch P, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S. Kronenberger B, et al. Among authors: zeuzem s. Eur J Gastroenterol Hepatol. 2007 Aug;19(8):639-46. doi: 10.1097/MEG.0b013e3281ac20ca. Eur J Gastroenterol Hepatol. 2007. PMID: 17625432 Clinical Trial.

8

Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.

Kronenberger B, Zeuzem S, Sarrazin C, Mihm U, von Wagner M, Hofmann WP, Piiper A, Herrmann E. Kronenberger B, et al. Among authors: zeuzem s. Antivir Ther. 2007;12(5):779-87. Antivir Ther. 2007. PMID: 17713161 Clinical Trial.

9

Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

ter Borg MJ, Hansen BE, Herrmann E, Zeuzem S, Cakaloglu Y, Karayalcin S, Flisiak R, van' t Veen A, de Man RA, Schalm SW, Janssen HL, Haagmans BL; HBV 99-01 Study Group. ter Borg MJ, et al. Among authors: zeuzem s. Antivir Ther. 2007;12(8):1285-94. Antivir Ther. 2007. PMID: 18240868

10

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.

Pugnale P, Herrmann E, Neumann AU, Pawlotsky JM, Schalm SW, Ferrari C, Homburger Y, Zeuzem S, Negro F; DITTO-HCV Study Group. Pugnale P, et al. Among authors: zeuzem s. J Hepatol. 2008 Jun;48(6):932-8. doi: 10.1016/j.jhep.2008.02.018. Epub 2008 Mar 31. J Hepatol. 2008. PMID: 18433918 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,196 results

Search Page

Filters